1,200
Participants
Start Date
November 30, 2020
Primary Completion Date
September 20, 2021
Study Completion Date
June 30, 2024
Questionnaire administration,blood sampling and genetic analyses.
"Adults (≥18 years) living in Bergamo and in all the towns of its territory shall be invited to voluntarily complete a questionnaire, with their personal data and information on SARS-CoV-2 clinical history (swab test and serologic test results, clinical symptoms, treatments, hospital care) and other previous conditions. Subjects considered fit for the genetic study will be asked to report to the Daccò Clinical Center for an interview, during which the data entered in the questionnaire will be reviewed and implemented, the informed consent for participation in the genetic investigations will be collected and blood sampling will be carried out.~Genetic: Exome sequencing and genotyping of host genome of individuals infected with SARS-CoV-2 and showing severe disease (cases), or infected with SARS-CoV-2 and showing mild disease or remaining asymptomatic, and in individuals without evidence of infection with SARS-CoV-2 (negative sierology)."
"Centro di Ricerche Cliniche per le Malattie Rare Aldo e Cele Daccò", Ranica
Mario Negri Institute for Pharmacological Research
OTHER